KKR and Ampersand Capital Partners have made a $400 million bid to acquire Oxford Immunotec Global Plc, reported Reuters. Oxford Immunotec is a medical diagnostics company that develops tests to identify tuberculosis.
Source: Reuters
KKR and Ampersand make takeover bid for Oxford Immunotec: Reuters
KKR and Ampersand Capital Partners have made a $400 million bid to acquire Oxford Immunotec Global Plc, reported Reuters.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.